Golden has been acquired by ComplyAdvantage.Read about it here ⟶

‌

US Patent 6989369 Kunitz domain peptides

Patent 6989369 was granted and assigned to Dyax on January, 2006 by the United States Patent and Trademark Office.

Overview Structured Data Issues Contributors Activity

Is a

0

Patent attributes

Current Assignee

0

Patent Jurisdiction

United States Patent and Trademark Office

0

Patent Number

Patent Inventor Names

Arthur C. Ley0

Robert Charles Ladner0

Date of Patent

January 24, 2006

0

Patent Application Number

103619970

Date Filed

February 7, 2003

0

Patent Citations Received

US Patent 12084515 Compositions and methods for treatment of diabetic macular edema

0

Patent Primary Examiner

0

Patent abstract

The invention relates to a Kunitz domain peptide, designated DPI-14 herein, for inhibiting human neutrophil elastase. The invention also relates to a method of using a DPI-14 for treating cystic fibrosis or cystic fibrosis-related disease or disorder.

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like US Patent 6989369 Kunitz domain peptides

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Golden Query Tool

By using this site, you agree to our Terms of Service.